Teva Pharmaceuticals Usa

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg/Actuation

First Posted Date
2012-02-01
Last Posted Date
2012-02-01
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
800
Registration Number
NCT01523236

Donepezil 10 mg Tablets Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Aricept®
Drug: Donepezil
First Posted Date
2011-09-23
Last Posted Date
2011-09-23
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
36
Registration Number
NCT01439230
Locations
🇨🇦

Anapharm, Montreal, Quebec, Canada

Donepezil 10 mg Tablets Under Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Aricept®
Drug: Donepezil
First Posted Date
2011-09-23
Last Posted Date
2011-09-23
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
26
Registration Number
NCT01439243
Locations
🇨🇦

Anapharm, Montreal, Quebec, Canada

Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions

First Posted Date
2011-04-29
Last Posted Date
2011-05-30
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
36
Registration Number
NCT01344369
Locations
🇺🇸

Novum Pharmaceutical Research Services, Houston, Texas, United States

Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting Conditions

First Posted Date
2011-04-22
Last Posted Date
2011-05-25
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
36
Registration Number
NCT01340625
Locations
🇺🇸

PRACS Institute, Ltd., Fargo, North Dakota, United States

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Sprinkle Study

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Venlafaxine Hydrochloride
Drug: Effexor® XR
First Posted Date
2011-01-25
Last Posted Date
2011-03-08
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
24
Registration Number
NCT01282814
Locations
🇨🇦

Anapharm Inc., Sainte-Foy, Quebec, Canada

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Venlafaxine Hydrochloride
Drug: Effexor® XR
First Posted Date
2011-01-25
Last Posted Date
2011-03-08
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
18
Registration Number
NCT01282801
Locations
🇨🇦

Anapharm Inc., Sainte-Foy, Quebec, Canada

10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Fasting Conditions.

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Aricept®
Drug: Donepezil Hydrochloride
First Posted Date
2010-12-15
Last Posted Date
2011-02-21
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
26
Registration Number
NCT01260922
Locations
🇺🇸

PRACS Institute, Ltd., East Grand Forks, Minnesota, United States

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Effexor® XR
Drug: Venlafaxine Hydrochloride
First Posted Date
2010-12-15
Last Posted Date
2011-02-21
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
24
Registration Number
NCT01260896
Locations
🇨🇦

Anapharm Inc., Sainte-Foy, Quebec, Canada

10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Non-Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Aricept®
Drug: Donepezil Hydrochloride
First Posted Date
2010-12-15
Last Posted Date
2011-02-21
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
26
Registration Number
NCT01260948
Locations
🇺🇸

PRACS Institute, Ltd., East Grand Forks, Minnesota, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy